| 2023 |
Dhakal, B., Li, C. M. Y., Ramezanpour, M., Houtak, G., Li, R., Bouras, G., . . . Fenix, K. (2023). Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiation. Frontiers in Immunology, 14, 13 pages.
DOI Scopus2 WoS1 Europe PMC1 |
| 2022 |
Dhakal, B., Li, C. M. Y., Li, R., Yeo, K., Wright, J. A., Gieniec, K. A., . . . Fenix, K. (2022). The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing. Cancers, 14(4), 16 pages.
DOI Scopus7 WoS7 Europe PMC7 |
| 2018 |
Surikow, S. Y., Nguyen, T. H., Stafford, I., Chapman, M., Chacko, S., Singh, K., . . . Horowitz, J. D. (2018). Nitrosative stress as a modulator of inflammatory change in a model of Takotsubo syndrome. JACC: Basic to Translational Science, 3(2), 213-226.
DOI Scopus46 WoS44 Europe PMC19 |
| 2018 |
Licari, G., Milne, R., Somogyi, A., & Sallustio, B. (2018). Enantioselectivity in the tissue distribution of perhexiline contributes to different effects on hepatic histology and peripheral neural function in rats. Pharmacology Research and Perspectives, 6(3), e00406.
DOI Scopus3 WoS3 Europe PMC2 |
| 2017 |
Panagopoulos, V., Leach, D., Zinonos, I., Ponomarev, V., Licari, G., Liapis, V., . . . Evdokiou, A. (2017). Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment. International Journal of Oncology, 50(4), 1191-1200.
DOI Scopus37 WoS32 Europe PMC25 |
| 2015 |
Chong, C., Drury, N., Licari, G., Frenneaux, M., Horowitz, J., Pagano, D., & Sallustio, B. (2015). Stereoselective handling of perhexiline: implications regarding accumulation within the human myocardium. European Journal of Clinical Pharmacology, 71(12), 1485-1491.
DOI Scopus11 WoS9 Europe PMC6 |
| 2015 |
Licari, G., Somogyi, A., Milne, R., & Sallustio, B. (2015). Comparison of CYP2D metabolism and hepatotoxicity of the myocardial metabolic agent perhexiline in Sprague-Dawley and Dark Agouti rats. Xenobiotica, 45(1), 3-9.
DOI Scopus3 WoS3 Europe PMC1 |
| 2015 |
Chong, C., Liu, S., Licari, G., Heresztyn, T., Chirkov, Y., Ngo, D., & Horowitz, J. (2015). Reversal of hyperglycemia: effects on nitric oxide signaling. American Journal of Medicine, 128(4), 427-430.
DOI Scopus6 WoS6 Europe PMC5 |
| 2015 |
Liu, S., Ngo, D., Chong, C., Amarasekera, A., Procter, N., Licari, G., . . . Horowitz, J. (2015). Suppression of neutrophil superoxide generation by BNP is attenuated in acute heart failure: a case for 'BNP resistance'. European Journal of Heart Failure, 17(5), 475-483.
DOI Scopus10 WoS9 Europe PMC8 |
| 2015 |
Westley, I., Licari, G., & Sallustio, B. (2015). Validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of perhexiline and cis-hydroxy-perhexiline plasma concentrations. Therapeutic Drug Monitoring, 37(6), 821-826.
DOI Scopus2 WoS1 Europe PMC1 |
| 2015 |
Surikow, S., Raman, B., Licari, J., Singh, K., Nguyen, T., & Horowitz, J. (2015). Evidence of nitrosative stress within hearts of patients dying of Tako-tsubo cardiomyopathy. International Journal of Cardiology, 189(1), 112-114.
DOI Scopus23 WoS23 Europe PMC13 |
| 2014 |
Drury, N., Licari, G., Chong, C., Howell, N., Frenneaux, M., Horowitz, J., . . . Sallustio, B. (2014). Relationship between plasma, atrial and ventricular perhexiline concentrations in humans: insights into factors affecting myocardial uptake. British Journal of Clinical Pharmacology, 77(5), 789-795.
DOI Scopus9 WoS9 Europe PMC8 |
| 2013 |
Dautov, R., Ngo, D., Licari, G., Liu, S., Sverdlov, A., Ritchie, R., . . . Chirkov, Y. (2013). The nitric oxide redox sibling nitroxyl partially circumvents impairment of platelet nitric oxide responsiveness. Nitric Oxide-Biology and Chemistry, 35, 72-78.
DOI Scopus21 WoS21 Europe PMC11 |
| 2011 |
Licari, G., Somogyi, A. A., Milne, R. W., & Sallustio, B. C. (2011). MYOCARDIAL AND HEPATIC DISPOSITION OF THE ENANTIOMERS OF PERHEXILINE. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 109, 152. |
